Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.